{"name":"Diasome Pharmaceuticlas, Inc.","slug":"diasome-pharmaceuticlas-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOVWpFNGNNY3hqQXN1TGFKNmhyU1VDQUk4Z1FhQV9YbDY2a3NyZTUwZTlUZlRzblFleG9IQmJ1LVk3MXNaejZhNVNEZE1hZGtySWVNQ1FHWUh6MXJoSDBiekhGSjJXbU9tc3hoeVdJSWh2bjhvUVdHYjdzS1V2aEQtMncyT1NvOWFlV1NhRF9YUFNGZ0EzMU5hOHZ3SjdrX3JHQ1N6SXJnUlVzaWw5V2RUZzVucUdHZFNkNzNkdHh3dw?oc=5","date":"2024-12-26","type":"pipeline","source":"bizjournals.com","summary":"What Inno's top 10 stories of 2024 say about Cleveland tech - bizjournals.com","headline":"What Inno's top 10 stories of 2024 say about Cleveland tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOOUJGdnhBVWFBelcweUtPRWY5YnFyRUhhUmZmM0cxekVYTUl0alNpSzlMWXplSV9sbkdrd3BzbHd3aDVCUFEyWXdpcHh5aVBKSWFlcTZkWVkycld5cEExcExYbFVKR1R3bGJ4bjdMRS1hUTNtLWJFLUtMTTJWbklqS1BHLWNUc0hFT2RWRnVIM0ROUzdSeVpvRg?oc=5","date":"2024-08-12","type":"trial","source":"Making Sense of Diabetes","summary":"New Study Tests Liver-Targeted Insulin in Type 1 Diabetes - Making Sense of Diabetes","headline":"New Study Tests Liver-Targeted Insulin in Type 1 Diabetes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5QQ3JKVzhLckdRem9xbHVyaTlLamo3bVBhVUwxeWMzOVNFdERaV21LR1Y2Z0VBcnV3UWR0eElUNFZFV2lOTE9JVU5wUmJvUjJ3TXFEOGppMHJjWG9kSWJ6QVB2NW1hV0Frbk1EX0J3?oc=5","date":"2024-06-04","type":"pipeline","source":"Labiotech.eu","summary":"Ohio’s finest: Eight biotech companies leading the way - Labiotech.eu","headline":"Ohio’s finest: Eight biotech companies leading the way","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPbFBTaG5qMUZ3a2d2QWZDdnA1cE05MXA5NVRjWm94eW1zYkEzcXdWOVVjNG5uOHFIYTZmaDZxelBSaUpZNGNYRzJpRTdic25KNGdZamthLWR5akc0dHIyMDNJTVpNUU5LekMxVzYtd21BVjlDQ2FRY2dxNEhRSVBKM01YbVVtSVhTUWhFeVYwVWZVei1hUkdtWUotcW5idnVjR2IyT3RHdTl1Qlg0M2RPaEZrU0MzNlFlLTd0MnJIeWR3OExU?oc=5","date":"2024-02-02","type":"pipeline","source":"bizjournals.com","summary":"Diasome Pharmaceuticals could tap $100 billion market for obesity drugs - bizjournals.com","headline":"Diasome Pharmaceuticals could tap $100 billion market for obesity drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxOamRMWjNBTk5DUXpsbmxBZ01sY0lYQXc3a2VhbC12QmhMSHE5T0lMX1VXWlM3aW1UWlpwU3NSMldCSE9OTnNoUi11Qk9oVW5YY1VvcU9FenNfYzFBcXhGcXpoZ1JSOG5GMkNSV0UyZ3NsZVV6eUV2Qkx4RVVMZ21IYUxNcEh4OTZFdEc5MnFlcDFwQkFKek0wTDdHdWM5SnBWVnRITkNuY25pVDBteF9DX2ZLLUdRZFc4VTQwV1kyeEp3M1lTX0hLNnVpTHlLX0RzbWVFTUhVR1Bpc0luNkhNTlVVU3dmZzVaaE5QVGk5ZE9sZ1lPd0VwRXpfMXZFemlMSjBuLVdnZmhMSDRVTjNYaXNJNlY?oc=5","date":"2022-07-13","type":"pipeline","source":"GlobeNewswire","summary":"Eli Lilly and Co and Novo Nordisk AS Among Leading - GlobeNewswire","headline":"Eli Lilly and Co and Novo Nordisk AS Among Leading","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNdWhzdjNhUlhBVGFtUFFsbXV0MnVUM0UyUmR5SUZZbUVOR0hYLVRPRVItX2tIVHF0R0hrQl9iUmhCZUFGZnF2TmdCRmlPNUxVbWkxS1V0UGQxcFlmWE14eEM5aTA4LUtpbWFNSVAyRkF1QzJudTlyZV9GQzM5SEg2bUIxekFCVUZqLUI5OUp5OHFOa1lrTVd3UTVKV1R4MGRRelMzQzBR?oc=5","date":"2019-02-14","type":"pipeline","source":"GlobeNewswire","summary":"Diasome Provides Company Update - GlobeNewswire","headline":"Diasome Provides Company Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQTGtXNjZ1SGZJM2M1WnZWZUo4cmtfRDVhd29BTEQ1X3pwRjFPd0oweFlkeTFlemRsNzdwWnd5Um5UeUZNYWJsM3JwaVVmLTlhN3Y4RTVtc0xqRzVjaHFPblliYzVqVXlsU09xZUdMa1JCUjJ5Q0JNYWtMNWR0bnp3V3oxY1FwcTEtNjlZS1pn?oc=5","date":"2016-09-17","type":"pipeline","source":"Diabetes In Control","summary":"Dr. Robert Geho, Part 1 – Diasome Drug Delivery System - Diabetes In Control","headline":"Dr. Robert Geho, Part 1 – Diasome Drug Delivery System","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}